GENT, Belgium--(BUSINESS WIRE)--FEops, a digital health leader in personalized predictive planning for structural heart interventions, is proud to announce having modeled 2000 patients with FEops ...
GENT, Belgium--(BUSINESS WIRE)--FEops, a cloud-based digital health player in the structural heart space, announces that it has secured a convertible loan of EUR 3.3m from its current investors and ...
CAMBRIDGE, Mass., Oct. 10, 2023 /PRNewswire/ -- Concert AI's TeraRecon, the advanced visualization and clinical AI SaaS company, announces the addition of FEops as the latest Clinical AI solution to ...
Data from the PRECISE-TAVI study, presented at the PCR Valves 2022 convention in London shows that Transcatheter Aortic Valve Implantation (TAVI) procedures planned by means of FEops HEARTguide TM ...
GENT, Belgium, October 10, 2023--(BUSINESS WIRE)--FEops, a leader in personalized predictive planning for structural heart interventions, announced today its partnership with ConcertAI's TeraRecon, ...
GENT, Belgium–(BUSINESS WIRE)–Data from the PREDICT-LAA trial, presented at the Late-Breaking Innovation session at the TCT 2022 convention in Boston shows that Left Atrial Appendage occlusion (LAAO) ...
Feops NV hopes to raise €10 million (US$10.67 million) in a series C fundraising round that will allow the company to scale up its operations worldwide. This follows the release of a study in JACC: ...
GENT, Belgium–(BUSINESS WIRE)–FEops, a leader in personalized predictive planning for structural heart interventions, is proud to announce that FEops HEARTguide TM was the winning entry at CSI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results